Braveheart Bio (BRVE) shares rose 69.8% in Thursday trading after the company announced an upsized initial public offering of 21.25 million common shares late Wednesday.
The stock opened for trading Thursday at $30.20, compared with its public offering price of $18 per share.
The offering is expected to close Friday, subject to customary closing conditions.
Price: 30.53, Change: +12.53, Percent Change: +69.58
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.